5 Spam-Free Article(s) Found
||Johnson & Johnson
May 21, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix
May 20, 2019 - Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
May 20, 2019 - AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
May 16, 2019 - Geron hints at a way forward for imetelstat in myelofibrosis, but the market isn't buying it.